Target intelligence / Profile preview

Sialic acid-binding Ig-like lectin 12 pseudogene

Molecular classification
Pseudogene, Immunoglobulin superfamily-related gene, Sialic acid-binding Ig-like lectin (related; not a functional member)
01

Overview

Sialic acid-binding Ig-like lectins (Siglecs) are a family of cell surface proteins that mediate interactions with sialylated glycoproteins and glycolipids, playing roles in immune regulation and cell signaling[2][4]. Sialic acid-binding Ig-like lectin 12 (SIGLEC12 or Siglec-XII) is a member of this family, with some functional alleles discussed in the literature (notably, functional SIGLEC12 is encoded by the SIGLEC12 gene, not a pseudogene)[4]. However, the entity ENSG00000268711 corresponds to a pseudogene—a non-functional remnant of SIGLEC12—which does not produce a functional protein product. Pseudogenes have lost protein-coding ability due to mutations and are generally not considered drug targets or relevant for direct therapeutic intervention. If you are interested in the therapeutic relevance of the functional SIGLEC12 protein, note that research indicates certain SIGLEC12 alleles may be linked to the progression of some carcinomas[4]. However, the majority of humans carry a SIGLEC12 allele that produces a non-functional version of the protein[4]. The pseudogene (ENSG00000268711) itself has no known biological or clinical significance.

Other names
SIGLEC12 pseudogenesialic acid-binding Ig-like lectin 12 pseudogeneSIGLEC12P

Beyond the preview

Go deeper on Sialic acid-binding Ig-like lectin 12 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid-binding Ig-like lectin 12 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call